1. Home
  2. OGEN vs BNRG Comparison

OGEN vs BNRG Comparison

Compare OGEN & BNRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OGEN
  • BNRG
  • Stock Information
  • Founded
  • OGEN 1996
  • BNRG 2012
  • Country
  • OGEN United States
  • BNRG Israel
  • Employees
  • OGEN N/A
  • BNRG N/A
  • Industry
  • OGEN Biotechnology: Pharmaceutical Preparations
  • BNRG
  • Sector
  • OGEN Health Care
  • BNRG
  • Exchange
  • OGEN Nasdaq
  • BNRG Nasdaq
  • Market Cap
  • OGEN 5.4M
  • BNRG 5.4M
  • IPO Year
  • OGEN N/A
  • BNRG 2022
  • Fundamental
  • Price
  • OGEN $1.10
  • BNRG $1.43
  • Analyst Decision
  • OGEN
  • BNRG
  • Analyst Count
  • OGEN 0
  • BNRG 0
  • Target Price
  • OGEN N/A
  • BNRG N/A
  • AVG Volume (30 Days)
  • OGEN 77.5K
  • BNRG 79.1K
  • Earning Date
  • OGEN 11-11-2025
  • BNRG 09-30-2025
  • Dividend Yield
  • OGEN N/A
  • BNRG N/A
  • EPS Growth
  • OGEN N/A
  • BNRG N/A
  • EPS
  • OGEN N/A
  • BNRG N/A
  • Revenue
  • OGEN N/A
  • BNRG $387,000.00
  • Revenue This Year
  • OGEN N/A
  • BNRG N/A
  • Revenue Next Year
  • OGEN N/A
  • BNRG N/A
  • P/E Ratio
  • OGEN N/A
  • BNRG N/A
  • Revenue Growth
  • OGEN N/A
  • BNRG 843.90
  • 52 Week Low
  • OGEN $1.01
  • BNRG $1.35
  • 52 Week High
  • OGEN $18.90
  • BNRG $15.30
  • Technical
  • Relative Strength Index (RSI)
  • OGEN 34.25
  • BNRG 35.28
  • Support Level
  • OGEN $1.12
  • BNRG $1.35
  • Resistance Level
  • OGEN $1.34
  • BNRG $1.50
  • Average True Range (ATR)
  • OGEN 0.07
  • BNRG 0.09
  • MACD
  • OGEN -0.03
  • BNRG -0.02
  • Stochastic Oscillator
  • OGEN 5.49
  • BNRG 16.74

About OGEN Oragenics Inc.

Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The Company operates in one reportable segment, which includes activities related to advancing the development of its concussion drug, ONP-002.

About BNRG Brenmiller Energy Ltd

Brenmiller Energy Ltd is a technology company that develops, produces, markets, and sells thermal energy storage. The technology of the company allows electrification and decarbonization of the industrial industry sector for integration with renewable energy sources and further reduction of carbon emissions.

Share on Social Networks: